Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Mukul Gupta

Oncology
Sutter Health
Ridley-Tree Cancer Center
540 West Pueblo Street, 
Santa Barbara, CA 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth

Advanced in WT1-Related Wilms Tumor Syndromes
Sutter Health
Ridley-Tree Cancer Center
540 West Pueblo Street, 
Santa Barbara, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mukul Gupta is an Oncologist in Santa Barbara, California. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, Lynch Syndrome, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Zambia School Medicine
Residency
LAC Los Angeles County+USC Medical Center
Specialties
Oncology
Licenses
Internal Medicine in CA
Fellowships
LAC Los Angeles County+USC Medical Center
Hospital Affiliations
Santa Barbara Cottage Hospital
Santa Ynez Valley Cottage Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Ridley-Tree Cancer Center
540 West Pueblo Street, Santa Barbara, CA 93105
Call: 805-879-0670

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd
Enrollment Status: Recruiting
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: ARX788
Study Phase: Phase 2
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
An Adaptive Phase III, Multicenter, Randomized, Open-Label, Controlled Study of M7824 (Bintrafusp Alfa) Versus Pembrolizumab as a First-line Treatment in Patients With PD-L1 Expressing Advanced Non-small Cell Lung Cancer
An Adaptive Phase III, Multicenter, Randomized, Open-Label, Controlled Study of M7824 (Bintrafusp Alfa) Versus Pembrolizumab as a First-line Treatment in Patients With PD-L1 Expressing Advanced Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug
Study Drugs: M7824, Pembrolizumab
Study Phase: Phase 3
A Phase III, Multicenter, Randomized, Double Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Canakinumab Versus Placebo as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II -IIIA and IIIB (T>5cm N2) Completely Resected (R0) Non-small Cell Lung Cancer (NSCLC)
A Phase III, Multicenter, Randomized, Double Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Canakinumab Versus Placebo as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II -IIIA and IIIB (T>5cm N2) Completely Resected (R0) Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Canakinumab
Study Phase: Phase 3
A Phase 1b/2 Study of Viagenpumatucel-L (HS-110) in Combination With Multiple Treatment Regimens in Patients With Non-Small Cell Lung Cancer (The DURGA Trial)
A Phase 1b/2 Study of Viagenpumatucel-L (HS-110) in Combination With Multiple Treatment Regimens in Patients With Non-Small Cell Lung Cancer (The DURGA Trial)
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Biological, Drug
Study Drugs: Viagenpumatucel-L, Nivolumab, Pembrolizumab, Pemetrexed
Study Phase: Phase 1/Phase 2
A Phase 2, Multi-Center, Open-Label Study of Cinrebafusp Alfa (PRS-343) in Combination With Ramucirumab and Paclitaxel in Patients With HER2-Positive Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma and in Combination With Tucatinib in Patients With HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
A Phase 2, Multi-Center, Open-Label Study of Cinrebafusp Alfa (PRS-343) in Combination With Ramucirumab and Paclitaxel in Patients With HER2-Positive Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma and in Combination With Tucatinib in Patients With HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2022
Intervention Type: Drug
Study Drugs: Cinrebafusp alfa, Ramucirumab, Paclitaxel, Tucatinib
Study Phase: Phase 2
View 5 Less Clinical Trials

4 Total Publications

Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential.
Conventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential.
Journal: Cancers
Published: July 11, 2023
View All 4 Publications
Similar Doctors
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Sarmen V. Sarkissian
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Sarmen V. Sarkissian
Hematology Oncology | Hematology | Oncology

County Of Ventura

300 Hillmont Ave, 
Ventura, CA 
 (28.9 miles away)
805-652-6000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sarmen Sarkissian is a Hematologist Oncology specialist and a Hematologist in Ventura, California. Dr. Sarkissian is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Colorectal Cancer.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Donald Hannoun
Oncology | Urology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Donald Hannoun
Oncology | Urology
23823 Valencia Boulevard, Suite 250, 
Santa Clarita, CA 
 (61.6 miles away)
661-799-1999
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Donald Hannoun is an Oncologist and an Urologist in Santa Clarita, California. Dr. Hannoun is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Obstructive Uropathy, Reconstructive Urology Surgery, and Ureteroscopy. Dr. Hannoun is currently accepting new patients.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Gregg Newman
Oncology
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Gregg Newman
Oncology

Ridley-Tree Cancer Center

540 West Pueblo Street, 
Santa Barbara, CA 
 (0.1 miles away)
805-879-0670
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Gregg Newman is an Oncologist in Santa Barbara, California. Dr. Newman is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Myelodysplastic Syndrome (MDS), Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gupta's expertise for a condition
ConditionClose
      • Advanced
      • Chromophobe Renal Cell Carcinoma
        Dr. Gupta is
        Advanced
        . Learn about Chromophobe Renal Cell Carcinoma.
        See more Chromophobe Renal Cell Carcinoma experts
      • Clear Cell Sarcoma
        Dr. Gupta is
        Advanced
        . Learn about Clear Cell Sarcoma.
        See more Clear Cell Sarcoma experts
      • Colorectal Cancer
        Dr. Gupta is
        Advanced
        . Learn about Colorectal Cancer.
        See more Colorectal Cancer experts
      • Familial Colorectal Cancer
        Dr. Gupta is
        Advanced
        . Learn about Familial Colorectal Cancer.
        See more Familial Colorectal Cancer experts
      • Familial Pancreatic Cancer
        Dr. Gupta is
        Advanced
        . Learn about Familial Pancreatic Cancer.
        See more Familial Pancreatic Cancer experts
      • Familial Wilms Tumor 2
        Dr. Gupta is
        Advanced
        . Learn about Familial Wilms Tumor 2.
        See more Familial Wilms Tumor 2 experts
      View All 11 Advanced Conditions
      • Experienced
      • Acute Lymphoblastic Leukemia (ALL)
        Dr. Gupta is
        Experienced
        . Learn about Acute Lymphoblastic Leukemia (ALL).
        See more Acute Lymphoblastic Leukemia (ALL) experts
      • Acute Myeloblastic Leukemia with Maturation
        Dr. Gupta is
        Experienced
        . Learn about Acute Myeloblastic Leukemia with Maturation.
        See more Acute Myeloblastic Leukemia with Maturation experts
      • Acute Myeloblastic Leukemia without Maturation
        Dr. Gupta is
        Experienced
        . Learn about Acute Myeloblastic Leukemia without Maturation.
        See more Acute Myeloblastic Leukemia without Maturation experts
      • Acute Myeloid Leukemia (AML)
        Dr. Gupta is
        Experienced
        . Learn about Acute Myeloid Leukemia (AML).
        See more Acute Myeloid Leukemia (AML) experts
      • Acute Promyelocytic Leukemia
        Dr. Gupta is
        Experienced
        . Learn about Acute Promyelocytic Leukemia.
        See more Acute Promyelocytic Leukemia experts
      • Adult Soft Tissue Sarcoma
        Dr. Gupta is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      View All 70 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved